Exome sequencing identifies cancer predisposition-gene carriers screening guidelines miss

Whole-exome sequencing identified carriers of predisposition genes for hereditary breast and ovarian cancer or Lynch syndrome who, under current guidelines, would not have qualified for genetic testing, according to study results.The findings, presented at American Association for Cancer Research Annual Meeting, highlighted the need for wide genomic screening for inherited autosomal dominant

Related Keywords

Minnesota , United States , Orlando , Florida , Arizona , American , Byjennifer Southall , N Jewel Samadder , Mindy Valcarcel , Mayo Clinic Center , American Association For Cancer Research Annual Meeting , Mayo Clinic College Of Medicine , Population Health Action Collaborative , Mayo Clinic Comprehensive Cancer Center , American Association , Cancer Research Annual Meeting , Individualized Medicine , Mayo Clinic College , Mayo Clinic ,